LTS Lohmann leads investment in needle-free delivery specialist
Fierce Pharma
NOVEMBER 29, 2022
LTS Lohmann leads investment in needle-free delivery specialist. Tue, 11/29/2022 - 10:21.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Fierce Pharma
NOVEMBER 29, 2022
LTS Lohmann leads investment in needle-free delivery specialist. Tue, 11/29/2022 - 10:21.
Fierce Pharma
NOVEMBER 22, 2022
Erytech pivots to extracellular vesicle drug delivery after lead candidate collapses. Tue, 11/22/2022 - 08:53.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
JANUARY 1, 2022
3hree: Pharma will increase its spending in digital, but a lot of the money will be wasted. Studies show that tens of millions of dollars are being wasted due to fraud with programmatic advertising, but many pharma companies are still wasting money on the channel. The post A realistic view of healthcare in 2022.
World of DTC Marketing
FEBRUARY 19, 2021
Included in the programmatic ad errors is Pfizer, who developed a leading COVID vaccine. When will pharma stop using programmatic online ads? Again and again, I have seen robust fraud and online ads being placed on sites that pharma would normally block in their system. Programmatic has been a thorn in online advertisers.
Pharma Marketing Network
DECEMBER 17, 2021
The pharma industry has been slower to embrace digital technologies than other less-regulated sectors but the COVID-19 pandemic has greatly changed this long-standing mindset. In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. In this article, R.J. COVID is Likely Here to Stay.
European Pharmaceutical Review
NOVEMBER 16, 2022
Bayer joined the top ten for the first time, with the broad geographic reach of its R&D plans highlighted as a best practice in the 2022 Index. 2022 Access to Medicine Index findings. The post Big Pharma leading in access-to-medicine strategies, shows data appeared first on European Pharmaceutical Review.
eMediWrite
JUNE 21, 2022
Every year, pharma marketing teams engage in multi-phased, cross-functional, multi-organizational strategic planning and also in aligning work-stream dubbed “Brand Planning” by many in the industry. From a general perspective, despite large gains in site traffic (+16%), pharma website engagement rates were down.
pharmaphorum
OCTOBER 11, 2022
The Reuters Pharma event 2022 began as a bustling industry affair yesterday, based out of the Nice Acropolis convention centre on France’s balmy south coast. The onus, he said, was on pharma to listen now. Patient engagement – what history teaches us about pharma’s future evolution. The purpose of these?
pharmaphorum
NOVEMBER 30, 2022
The event brought together some of the best and brightest minds working across pharma and healthcare to celebrate those setting the bar higher and broadening the possibilities for pharma by showing what can be achieved. On Thursday, 17 November, Reuters opened the doors for its first European awards ceremony.
European Pharmaceutical Review
OCTOBER 17, 2022
An Annex 1 and Pharma 4.0 Elements leading to a rational design of cyclodextrin-based formulations. US legislative update: takeaways for European pharma. The post European Pharmaceutical Review Issue 5 2022 appeared first on European Pharmaceutical Review. perspective on water quality. DRUG FORMULATION.
Pharmaceutical Technology
DECEMBER 27, 2022
The healthcare industry saw its share of ups and downs in 2022. In a recap of this eventful year, we take a moment to look at some of our biggest stories that relied on data and experts to inform our audience about the latest developments in the world of pharma, medical devices, and clinical trial operations. Tracking the news.
pharmaphorum
NOVEMBER 2, 2022
Wednesday 2 nd November heralds the start of Anthropy 2022 at The Eden Project. The post Anthropy 2022 – Day One appeared first on.
PharmaVoice
DECEMBER 7, 2022
From GSK to Roche to Biogen, these were the most impactful executive changes at leading pharma companies in 2022.
European Pharmaceutical Review
MAY 31, 2023
The inventory position of 28 major pharmaceutical manufacturers in 2022 has been revealed in an annual report. Analysis explored the impact of macro-trends on inventory management from corporate reports of Big Pharma companies including Merck, AstraZeneca and Pfizer. Sales grew by seven percent, totalling $994 billion in 2022.
PM360
AUGUST 29, 2022
Over-the-Counter (OTC) and Prescription (Rx) brands have invested over $3 billion in linear TV advertising during the first half of 2022, with no signs of letting up. Pharma ads generate strong consumer engagement and drive TV viewers to seek additional information online via a search engine such as Google. Brand / Creative.
Pharma Pathway
SEPTEMBER 13, 2022
Kekule Pharma Limited-Walk-Ins for QC/ QA/ Production/ R&D/ Regulatory Affairs/ Maintenance/ IT On 13th to 17th Sept’ 2022. Walk-Ins for Experienced Diploma/ ITI/ M.Sc / B.Sc/ Any Degree Candidates in QC/ QA/ Production/ R&D/ Regulatory Affairs/ Maintenance/ IT Departments @ Kekule Pharma Limited. Job Description.
MedCity News
MARCH 4, 2024
The latest Akero data build on six-month results reported in 2022. Akero Therapeutics’ preliminary Phase 2b data show that treatment with its MASH drug, efruxifermin, continued to distance itself from a placebo measured at nearly two years of treatment.
pharmaphorum
OCTOBER 14, 2022
A consortium of industry and academic groups – led by Johnson & Johnson’s pharma division Janssen – has been set up to tackle the environmental impact of digital health products, specifically aimed at minimising waste that could end up in landfill. — Circular Digital Health (DiCE project) (@circular_health) October 13, 2022.
European Pharmaceutical Review
NOVEMBER 3, 2022
Results from CPhI’s 2022 Pharma Index survey , announced at this year’s CPhI Frankfurt, showed pharma confidence in growth , innovation and manufacturing quality has reached record highs, promising positive prospects for the industry in 2023 and beyond. Key countries. Scores this year were the highest on record ( Figure 2 ).
Pharma Marketing Network
FEBRUARY 10, 2022
Experts from top life sciences companies discussed strategies for more effectively engaging oncologists at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Here are the top three things to know about engaging oncologists in 2022: 1. Lead with clinical education.
PM360
OCTOBER 28, 2022
Two of ZS’ major studies suggest that the trend towards more advanced KAM strategies and capabilities will continue to accelerate for pharma manufacturers. How should leading pharma companies respond? Consolidation among providers continues unabated, leading to larger and larger health systems. healthcare ecosystem.
Pharma Pathway
DECEMBER 2, 2022
Intas Pharmaceuticals Ltd-Walk-In Drive for M.Sc (Microbiology) in Quality Control On 7th Dec’ 2022. Company Profile: INTAS Pharmaceutical is a leading, vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. Date: 17th Dec’ 2022. Job Description. Position: Executive.
pharmaphorum
NOVEMBER 7, 2022
With more than a decade of experience leading and scaling managed care organisations, Grabski is a seasoned business leader and finance executive. In 2022, she won the CFO of the Year Award in the small business category from the San Diego Business Journal for her leadership in building and managing successful financial teams.
PM360
SEPTEMBER 23, 2022
NEW YORK, NY, September 23, 2022: PM360 , a leading life sciences marketing industry trade publication, announced the winners of their 14 th annual Trailblazer Awards during an event held at Gotham Hall in New York City on Thursday, September 22, 2022. COMPANY OF THE YEAR: SPECIALTY PHARMA/BIOTECH. Sherlock Biosciences.
Pharmaceutical Technology
APRIL 12, 2023
Clinical-stage biotechnology firm LyGenesis has formed a joint research collaboration with Imagine Pharma to develop new cell therapies for type 1 diabetes (T1D). In June 2022, the company discovered T1D AIPCs, a critical component to treat T1D through autologous cell transplantation. According to the company, around 1.45
Pharma Pathway
SEPTEMBER 6, 2022
Intas Pharmaceuticals Ltd-Walk-In Drive for Manufacturing/ Packaging Department On 9th Sept’ 2022. Company Profile: INTAS Pharmaceutical is a leading, vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. Date: 9th Sept’ 2022. Job Description. Designation: Officer/ Sr.
pharmaphorum
JANUARY 9, 2023
is to acquire the 2015-established Amryt Pharma Plc. Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 Biopharma and healthcare group Chiesi Farmaceutici S.p.A. on 6 th January.
Pharma Pathway
SEPTEMBER 23, 2022
Intas Pharmaceuticals Ltd-Walk-In Drive for Quality Control Department On 27th September 2022. Company Profile: INTAS Pharmaceutical is a leading, vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. Date: 27th Sept’ 2022. Job Description. Department: Quality Control.
pharmaphorum
NOVEMBER 23, 2022
Harking back to the Reuters Pharma 2022 event, held at the Nice Acropolis convention centre on France’s South Coast back in October, pharmaphorum had a chance to drop by the booth of EY and discuss not only its consulting operations, but the company’s Smart Reviewer, and their own assessment of the industry event itself.
Pharma Pathway
SEPTEMBER 15, 2022
Jubilant Biosys Ltd -Walk-In Drive for Multiple Positions On 17th & 18th Sept’ 2022. Virtual Recruitment Drive for Freshers & Experienced in Synthesis/ Discovery-R&D Jubilant Biosys Noida for multiple positions on On 17th & 18th Sept’ 2022. Date: 17th & 18th Sept’ 2022. Job Description.
Pharma Pathway
DECEMBER 7, 2022
Hetero Limited-Campus Placement Drive for Freshers -Production/ QA/ QC/ R&D On 9th, 13th, 17th, 22nd December 2022. HETERO is one of the India’s leading generic pharmaceutical companies and is one of the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. 9-12-2022 @ Siddipet. Job Description.
Pharma Pathway
SEPTEMBER 16, 2022
Hetero Labs Limited-Campus Placement Drive for Freshers On 17th Sept’ 2022. HETERO is one of the India’s leading generic pharmaceutical companies and is one of the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. Experience: 2019, 2020, 2021, 2022 passed outs only. Job Description.
Pharma Pathway
SEPTEMBER 13, 2022
Hetero Labs Limited-Walk-In Interviews for QA/ Production On 17th Sept’ 2022. HETERO is one of the India’s leading generic pharmaceutical companies and is one of the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. On 12th Sept’ 2022 @ Hetero Labs Ltd. Date of Interview: 17th Sept’ 2022.
Pharma Pathway
DECEMBER 12, 2022
On 20th Dec’ 2022. Known for our technological capabilities in Chemistry/ Engineering related services and on the other hand, have built leading brands over the last 75 years and connected with more than 70,000 retail points pan India. Date of Interview: 20th Dec’ 2022. On 20th Dec’ 2022. B.Tech, B.E
Pharmaceutical Technology
JANUARY 30, 2023
on National Health Service (NHS) sales of branded medicines in 2023, almost double that of the previous year, has sent shock waves through the pharma industry. During 2019–21, when sales being close to predicted levels resulted in single-digit payback rates, the scheme was relatively popular with the pharma sector. billion ($4.1
Pharma Pathway
SEPTEMBER 21, 2022
Hetero Labs Limited-Walk-In Interviews for EHS- Process Safety Management/ Process Safety Lab On 24th Sept’ 2022. HETERO is one of the India’s leading generic pharmaceutical companies and is one of the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. On 24th Sept’ 2022 @ Hetero Labs Ltd.
Pharma Pathway
DECEMBER 13, 2022
Hetero Labs Limited-Walk-In Interviews for Freshers in QA/ QC On 14th Dec’ 2022. HETERO is one of the India’s leading generic pharmaceutical companies and is one of the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. Pass out year: 2019/ 2020/2021/ 2022. Date of Interview: 14th Dec’ 2022.
Fierce Pharma
MAY 6, 2024
Following Nucleus RadioPharma’s 2022 debut, the GE HealthCare- and Mayo Clinic-backed radiopharmaceuticals CDMO is ready to put its production thesis to the test. The production deal will support ARTBIO’s planned phase 1 and 2 clinical trials of its lead program in prostate cancer, AB001.
PM360
AUGUST 9, 2022
The industry has been limited in its ability to implement creative solutions to engage and motivate patients because the FDA has strict guidelines for what pharma companies can communicate with patients. Yet, pharma companies spend more than $5 billion on patient support programs every year, and only 3% of patients are using them.
Pharma Pathway
DECEMBER 3, 2022
Hetero Labs Limited-Walk-In Interviews for Production/ Production Packing/ QA/QC / Engineering On 10th & 11th Dec’ 2022. HETERO is one of the India’s leading generic pharmaceutical companies and is one of the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. Job Description.
Pharma Pathway
SEPTEMBER 13, 2022
On 16th Sept’ 2022. HETERO is one of the India’s leading generic pharmaceutical companies and is one of the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. On 16th Sept’ 2022 @ Hetero Labs Ltd. Eligibility: 2019, 2020, 2021, 2022 passed outs Only. Date of Interview: 16th Sept’ 2022.
Pharma Pathway
SEPTEMBER 20, 2022
On 24th Sept’ 2022. SMS Pharmaceuticals Ltd is one of the leading pharmaceutical manufacturing companies in India with world -class facilities, with a wide range of process equipment fully compliant with the cGMP and WHO Standards. On 24th Sept’ 2022 @ SMS Pharmaceuticals Ltd, Unit-II, Bachupally, Hyderabad.
European Pharmaceutical Review
APRIL 21, 2023
2022; 6: 949-57. Let’s remember: the status quo or too little action will lead us into multiple ecological catastrophes that are a much greater threat to our economies, health and societies than any legislative change proposed in our policy brief could ever be. 2022; 6: 949-57. 3 Credit: Steenmeijer M, et al. 7(11): 942-965.
European Pharmaceutical Review
OCTOBER 5, 2022
But how is this push shaping the pharma packaging market and what are the key changes we can expect to see? 2 Pharmaceutical packaging providers looking to play their part in increasing consumer safety and stem the tide of the fake pharma market also have a responsibility to incorporate anti-counterfeit technology into their products.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content